 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/29/2023 |
$0.06 |
$0.07 |
$0.05 |
$0.06 |
47.80K | | 11/30/2023 |
$0.07 |
$0.07 |
$0.05 |
$0.06 |
52.00K | | 12/01/2023 |
$0.06 |
$0.07 |
$0.06 |
$0.06 |
6.70K | | 12/04/2023 |
$0.06 |
$0.07 |
$0.06 |
$0.07 |
37.80K | | 12/05/2023 |
$0.06 |
$0.06 |
$0.05 |
$0.05 |
910.20K |
 |
| ContraFect is a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLA), including lysins and amurin peptides, as new medical modalities for the treatment of antibiotic-resistant infections. Co.'s main DLA product candidate, exebacase, is being developed in patients with chronic prosthetic joint infections of the knee due to S. aureus or coagulase-negative Staphylococci. Co.'s other product candidate, CF-370, is designed to target gram-negative bacteria, including P. aeruginosa, K. pneumoniae and A. baumannii, and is effective in vivo activity against these pathogens, even against multidrug-resistant and extensively drug-resistant strains. | |
 |

CFRX (CFRX) has the following price history information. Looking back at CFRX historical stock prices for the last five trading days, on November 29, 2023, CFRX opened at $0.06, traded as high as $0.07 and as low as $0.05, and closed at $0.06. Trading volume was a total of 47.80K shares. On November 30, 2023, CFRX opened at $0.07, traded as high as $0.07 and as low as $0.05, and closed at $0.06. Trading volume was a total of 52.00K shares. On December 01, 2023, CFRX opened at $0.06, traded as high as $0.07 and as low as $0.06, and closed at $0.06. Trading volume was a total of 6.70K shares. On December 04, 2023, CFRX opened at $0.06, traded as high as $0.07 and as low as $0.06, and closed at $0.07. Trading volume was a total of 37.80K shares. On December 05, 2023, CFRX opened at $0.06, traded as high as $0.06 and as low as $0.05, and closed at $0.05. Trading volume was a total of 910.20K shares.
CFRX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CFRX shares, starting with a $10,000 purchase of CFRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/22/2016 |
|
| End date: |
12/05/2023 |
|
| Start price/share: |
$2,920.00 |
|
| End price/share: |
$0.05 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-100.00% |
|
| Average Annual Total Return: |
-75.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$0.17 |
|
| Years: |
7.87 |
|
|
 |
| Date |
Close |
| 11/29/2023 | $0.06 | | 11/30/2023 | $0.06 | | 12/01/2023 | $0.06 | | 12/04/2023 | $0.07 | | 12/05/2023 | $0.05 |
|
 |